InvestorsHub Logo
Followers 0
Posts 161
Boards Moderated 0
Alias Born 05/09/2007

Re: None

Tuesday, 06/29/2021 10:56:27 AM

Tuesday, June 29, 2021 10:56:27 AM

Post# of 459336
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company, is engaged in the development of drug candidates for the treatment of central nervous system (CNS) disorders. Its lead drug candidate is ANAVEX 2-73, which is in a Phase III clinical trial for the treatment of Alzheimer's disease; Phase III Study in the Treatment of Pediatric Patients with Rett Syndrome;
Grüße aus Germany
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News